George Georgiev
Bow Therapeutics
Affiliations
Albert Einstein College of Medicine
Technologies
Therapeutic
Indication
Autoimmune & Inflammation
Drug Discovery
Human Monoclonal Antibodies
Infectious Disease
Executive Summary
View/DownloadBow Therapeutics is developing isolation of human monoclonal antibodies against Chikungunya Virus Glycoprotein using Single B-cell sorting Technology.
